pancreatic cancer
Conditions
Interventions
None listed
Sponsors
Tohoku University
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: (1) Disease name: Pancreatic adenocarcinoma (Cases diagnosed histologically or cytologically as pancreatic adenocarcinoma. Class IV is included in cytological diagnosis) (2) Stage: Patients diagnosed with resectable pancreatic cancer or borderline resectable pancreatic cancer by imaging diagnosis at the time of initial diagnosis and indicated for resection or anticancer drug treatment. (3) Patients with positive cytological diagnosis by abdominal cavity washing: Patients who were diagnosed as Class IV or V equivalent by Papanicolaou classification. (4) Patients must be at least 20 years of age (at the time of CY1 diagnosis).
Exclusion criteria
Exclusion criteria: (1) Patients who have not been diagnosed as pancreatic adenocarcinoma histologically or cytologically (2) Patients diagnosed with distant metastasis by various imaging tests (3) Patients with active multiple cancers (synchronous multiple cancers and heterochronic multiple cancers with a disease-free period of 5 years or less) at the time of CY1 diagnosis (4) Patients diagnosed with Papanicolaou classification Class III or lower by laparoscopic cytology. (5) Other cases that the investigator(s) deems inappropriate for this study.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Prognostic comparison between surgical resection and non-surgical treatment for CY1 pancreatic cancer | — |
Countries
Japan
Contacts
Public ContactKyohei Ariake
Sendai Open Hospital Department of Surgery
Outcome results
None listed